Saturday 17 October 2026
Export MDAI’s income statement to Excel — free account
Spectral AI, Inc.
MDAI Healthcare Medical Devices
Spectral AI, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $19.7 million, down 33.6% from fiscal 2024. In the quarter to June 2026, revenue fell 30.4%, EPS grew 58.1%, free cash flow fell 21.9% and total debt rose 44.9%, each against the same quarter a year earlier.
1.51
0.03
−1.95%
Follow MDAI
| Dec '17 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | — | — | — | 5 | 3 |
P/E ratio |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z-Score |
— | — | — | 12.57 | (5.22) | (4.10) | (3.29) |
P/S ratio |
— | — | — | 0.00 | 1.97 | 1.72 | 1.92 |
P/FCF ratio |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
— | — | — | 2.81 | (19.84) | (21.13) | (11.78) |
Beneish M-Score |
— | — | — | — | (6.53) | (4.06) | (2.68) |
P/Operating CF |
— | — | — | (441.56) | (15.01) | 108.22 | (14.76) |
P/B ratio |
— | — | — | 11.01 | 0.00 | 0.00 | 0.00 |
Price to Tangible BV |
— | — | — | 11.01 | 0.00 | 0.00 | 0.00 |
EV/Sales |
— | — | — | 0.00 | 1.72 | 1.58 | 1.41 |
EV/EBITDA |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Operating CF |
— | — | — | (101.42) | (2.35) | (5.07) | (2.80) |
EV/FCF |
— | — | — | (101.42) | (2.35) | (5.07) | (2.80) |
Quick Ratio |
— | 0.00 | 0.26 | 2.58 | 0.58 | 0.43 | 0.81 |
Current Ratio |
— | 0.00 | 0.37 | 2.77 | 0.80 | 0.57 | 0.94 |
Net Debt/EBITDA |
— | 0.00 | 0.22 | 6.82 | 0.39 | 0.86 | 1.31 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 25.87% |
Debt/Equity |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | (0.97) |
Asset Turnover |
— | 0.00 | 0.00 | 0.19 | 1.23 | 2.60 | 1.17 |
Operating CF/Net income |
— | 0.00 | 1.74 | 0.40 | 0.63 | 0.61 | 1.31 |
Capex/Depreciation |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 |
| — | 0.00% | 4.56% | 65.97% | (405.44%) | 338.35% | 116.67% | |
| — | (0.85%) | (0.37%) | (2.13%) | (141.83%) | (133.04%) | (45.20%) | |
ROIC |
— | (1.80%) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Return on Tangible Assets |
— | 0.50% | 25.55% | (25.69%) | 838.52% | 201.57% | 827.43% |
Average Days of Receivables |
— | — | — | 33.01 | 47.42 | 30.91 | 23.53 |
Research and Development Expense of Revenue |
— | — | — | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
— | 0.00% | 0.00% | 53.15% | 115.55% | 67.12% | 89.20% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
— | — | — | 4.55% | 6.88% | 3.49% | 5.67% |
Graham Net Nets |
— | — | — | 0.08 | (0.07) | (0.18) | (0.20) |
Graham Number |
— | — | — | 0.00 | 2.02 | 2.76 | 1.19 |
Earnings Yield |
— | — | — | (2.21%) | (59.13%) | (29.68%) | (20.64%) |
Free Cash Flow Yield |
— | — | — | (0.88%) | (37.15%) | (18.12%) | (26.34%) |
Revenue per Share |
— | 0.00 | 0.00 | 1.93 | 1.28 | 1.65 | 0.74 |
Operating CF per Share |
— | 0.00 | (0.13) | (0.09) | (0.94) | (0.51) | (0.37) |
Capex per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Free Cash Flow per Share |
— | 0.00 | (0.13) | (0.09) | (0.94) | (0.51) | (0.37) |
Cash per Share |
— | 0.00 | 0.12 | 1.08 | 0.34 | 0.29 | 0.58 |
Shareholders Equity per Share |
— | 0.00 | (3.35) | 0.91 | (0.12) | (0.40) | (0.22) |
Interest Debt per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
— | 0.00 | (3.35) | 0.91 | (0.12) | (0.40) | (0.22) |
Free Cash Flow |
— | — | (0.83) | (1.16) | (13.24) | (9.20) | (9.92) |
Working Capital |
— | (0.14) | (1.85) | 11.31 | (2.50) | (7.52) | (1.17) |
Net Current Asset Value |
— | (0.14) | (273.85) | 10.97 | (2.50) | (9.22) | (7.68) |
EV/EBIT |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 |
Capex to Sales |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 |
Price to Operating Income |
— | — | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | |||||||
Depreciation/Fixed assets |
— | — | — | 27.05 | 60.17 | 294.00 | 4.22 |
Cash ROIC |
— | 0.00% | 4.12% | (4.44%) | (429.73%) | 439.30% | (65.24%) |
Accounts Receivable Turnover |
— | — | — | 0.00 | 7.78 | 12.20 | 10.42 |
Accounts Payable Turnover |
— | — | — | 0.00 | 3.74 | 4.85 | 3.04 |
Inventory Turnover |
— | — | — | 0.00 | 0.00 | 49.79 | 16.98 |
Average Days of Payables |
— | — | — | 69.30 | 96.24 | 90.32 | 102.44 |
Days of Inventory on Hand |
— | — | — | 0.00 | 8.25 | 9.51 | 28.52 |
Average Receivables |
— | — | — | — | 2.32 | 2.43 | 1.89 |
Average Payables |
— | — | — | — | 2.72 | 3.36 | 3.52 |
Average Inventory |
— | — | — | — | — | 0.33 | 0.63 |
Average Assets |
— | 0.08 | 127.14 | 136.41 | 14.70 | 11.39 | 16.75 |
Average Common Equity |
— | 116.10 | (10.40) | (4.41) | 5.14 | (4.48) | (6.49) |
Columns are period end dates